Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: Response to liver transplantation

Australasian Journal of Dermatology

Volumn 45, Issue 4, 2004, Pages 226-228

  Moyle, Mignon ^a   Tate, Bruce ^a  

^a SKIN AND CANCER FOUNDATION   (Australia)

Author keywords

Atorvastatin; Cholesterol; Plasma exchange; Treatment

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INFANT; LIVER TRANSPLANTATION; PHYSICAL EXAMINATION; PLASMAPHERESIS; TREATMENT OUTCOME; XANTHOMA;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; LIVER TRANSPLANTATION; SKIN NEOPLASMS; TRIGLYCERIDES; XANTHOMATOSIS;

EID: 8444234306     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2004.00103.x     Document Type: Article

References (7)

1. Goldstein JL, Hobbs HH, Brown HS. Familial hypercholesterolemia. In: Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (eds). The Metabolic and Molecular Bases of Inherited Disease, Vol. 3, 8th edn. New York: McGraw Hill, 2001; 2863-913.
2. Hoeg JM. Familial hypercholesterolemia: What the zebra can teach us about the horse. JAMA 1994; 271: 543-6.
3. Seymour CA. Xanthomas and abnormalities of lipid metabolism and storage. In: Champion RH, Burton JL, Burns AD, Breathnach SM (eds). Textbook of Dermatology, Vol. 3, 6th edn. Oxford: Blackwell Science, 1998; 2600-15.
4. Gordon BR, Kelsey SF, Bilheimer DW, Brown DC, Dau PC, Gotto AM et al. Treatment of refractory hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am. J. Cardiol. 1992; 70: 1010-16.
5. Lopez-Santamaria M, Migliazza L, Gamez M, Murcia J, Diaz-Gonzalez M, Camarena C et al. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J. Pediatr. Surg. 2000; 35: 630-3.
6. Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ, Kolansky DM, Muller DWM, Wilson JM. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann. Surg. 1996; 223: 116-26.
7. Lynch SV, Balderson GA (eds). ANZLT Registry Report. Brisbane: Australia and New Zealand Transplant Registry, 2003.